Navigation Links
Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Date:3/18/2008

HORSHAM, Pa. and KENILWORTH, N.J., March 18 /PRNewswire/ -- Centocor, Inc. and Schering-Plough Corporation (NYSE: SGP) announced today that a Marketing Authorization Application (MAA) has been submitted to the European Medicines Agency (EMEA) requesting the approval of golimumab (CNTO 148) as a monthly subcutaneous treatment for adults with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. The initial submission and Phase 3 development programs are unprecedented among anti-tumor necrosis factor (TNF)- alpha therapies, as they mark the first time that an MAA has been proposed for review inclusive of three unique disease states. Golimumab, Centocor's and Schering-Plough's next-generation human anti-TNF-alpha monoclonal antibody, is being studied as an every four week subcutaneous injection and an intravenous (IV) infusion therapy. Pending regulatory approval in the European Union, Schering-Plough Corporation (NYSE: SGP) will assume exclusive marketing rights for golimumab in Europe.

"We look forward to working with the EMEA so that patients and physicians might one day have the opportunity to experience golimumab as a therapeutic option for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis," said Jerome A. Boscia, M.D., senior vice president, Clinical Research and Development, Centocor, Inc. "We remain focused and on track for global regulatory submissions for golimumab targeted for the first half of 2008."

Phase 3 primary endpoint study findings from the Golimumab - A
'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
2. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
3. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
4. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
5. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
6. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
7. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
10. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
11. Schering-Plough Completes Acquisition of Organon BioSciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...July 3 /- On June 27, 2008,GeneraMedi...ug,Administration (FDA) for its Epoprostenol for I...rostenol for Injection 1.5 mg is indicated for the...ary hypertension and pulmonary,hypertension associ...YHA,Class III and Class IV patients who do not res...
(Date:7/3/2008)...swire-FirstCall/ -- Advanced Life Sciences,Holding...any engaged in the,discovery, development and comm...eas of infection, cancer and respiratory diseases,...Microcap(R) Index after the,Russell Investment Gro...,global equity indexes on June 27, 2008., (Logo: ...
(Date:7/3/2008)...uly 3 /- Senesco,Technologi...) announced today,that it has contracted with Poly...yplus,s "in vivo-jetPEI" for systemic delivery of ...tor 5A and a plasmid of the Factor,5A gene., Sene...n vivo results,using its combination siRNA and pla...
(Date:7/3/2008)...Xinhua-- Huifeng,Bio-Pharma...B), a leading,developer and producer of plant extr...harmaceutical, nutraceutical and food production i...ion will be made available via,Standard & Poor,s M...service that enables subscribing publicly traded c...
Breaking Biology Technology:GeneraMedix Inc. Receives Approval for Epoprostenol for Injection 1.5 mg 2Advanced Life Sciences Added to Russell Microcap Index 2Advanced Life Sciences Added to Russell Microcap Index 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 4Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program 2
...,, , , , , , , ...serve Cytotoxicity (greater than 5 - ,10 % Cell ...eagent has proven to be virtually nontoxic to most...cell death in transient transfection ,experiment...s, refer to the ,table below for possible causes...
..., , , , , , , Agencourt...compass all aspects of genome projects from shotgu...otation and pathway mapping. Our personal project ... sequencing strategy to meet their specific , ...roject from start to finish. , Our efforts ...
..., , , , , , , CosMCPrep...ication system that uses a single protocol to puri...template types. This flexible system is easily aut...s. The single protocol, ease of automation , ... solution for all template , purification n...
..., , , , , , , , ...gathered , regarding smeared bands after ... , , , , , ... href="#Option4">Primer annealing temperatur..., , , <a , ...
Other Biology Technology:Uses and Applications of FuGENE 6 Transfection Reagent 2Uses and Applications of FuGENE 6 Transfection Reagent 3WHOLE GENOME SEQUENCING 2WHOLE GENOME SEQUENCING 3COSMCPREP HIGH AND LOW COPY PLASMID PURIFICATION 2COSMCPREP HIGH AND LOW COPY PLASMID PURIFICATION 3Trouble-shooting: Smeared bands 2Trouble-shooting: Smeared bands 3Trouble-shooting: Smeared bands 4Trouble-shooting: Smeared bands 5
(Date:7/2/2008)...ate University have found that quantum dot nanopar...ion, providing insight into potential workplace co...ved in the manufacturing of quantum dots or doing ...he tiny nanoparticles. , While the study shows ...urface coatings do not penetrate rat skin unless t...
(Date:7/2/2008)...want to produce a lot of a substance -- such as a ...s, molecules that speed chemical reactions. Many j...ing one in just the right shape to connect with ce...s, such as enzymes in the human body that help us ...ting to suit the task at hand. , Chemists have m...
(Date:7/2/2008)...erman . , Metabolomics aims to determine the tot.... The exponents of bioinformatics analyzed data co...omics study in healthy and diabetic mice. In each ...he diabetes drug RoziglitazoneTM. Then, more than ...a blood plasma sample of a total of forty mice, re...
(Date:7/2/2008)...Spanish . , Most of the functions performed by ...eins, which recognise their binding partner by aff...here are many kinds of interactions; however, the ...structural biology are those which are transient. ...gh a large section of the protein surface- the glo...
Breaking Biology News(10 mins):Study shows quantum dots can penetrate skin through minor abrasions 2Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3Healthy or diseased? 2Scientists reveal the key mechanisms for affinity between transient binding proteins 2Summit on Spinal Muscular Atrophy 2319 1Immucor Schedules First Quarter Earnings Release and Conference Call 2316 1Immucor Schedules First Quarter Earnings Release and Conference Call 2316 2Avicena Appoints Dr M Flint Beal to Board of Directors 930 1Avicena Appoints Dr M Flint Beal to Board of Directors 930 2Avicena Appoints Dr M Flint Beal to Board of Directors 930 3Avicena Appoints Dr M Flint Beal to Board of Directors 930 4CardioDynamics Receives FDA 510 28k 29 Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility 927 1CardioDynamics Receives FDA 510 28k 29 Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility 927 2CardioDynamics Receives FDA 510 28k 29 Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility 927 3
...tudy published in the open-access journal PLoS Bio...ic collapse in orangutan populations living in the...anctuary in Sabah, Malaysia. Benoit Goossens, Loun...es report that the collapse occurred within the pa...decades--coinciding with massive deforestation, wh...
...mportant new study forthcoming from The American N...d tracked a colony of mute swans for more than two...estion: whether the number of eggs laid by a femal...nce with natural selection. , "Extensive debate in... Why does a population,s average clutch size diffe...
...prism of our senses, the human brain has ways of r...This is seen, for example, in the placebo effect, ...nwitting subjects are seen to ease pain or have so...brain processes this faked input and prompts the b...e. , Now, however, scientists have begun to peel ...
... are innately beautiful to the human eye, but how ...rsecting spirals or a daisy its delicate symmetry?...Calgary computer scientists, who have answered one...model that provides the most detailed simulation o...the article "A plausible model of phyllotaxis" pub...
Other Biology News:Genetic study shows humans have pushed orangutans to the brink of extinction 2Great (taste) expectations: Study shows brain anticipates taste, shifts gears 2Pleasing plant shapes explained by new computer model 2
...polyclonal antibody to the Salmonella Common Struc...a serum pool of goats immunized with different str...tive to Salmonella and recognizes all Salmonella s...for Group B and D Salmonella based upon the Kaufma...
Abgene's ALTO-8 is the first automated decapper/capper for Abgene Twist-Lock tubes.
...ilated and BR4i refrigerated multifunction centrif...ed operation at a low sound level with a large ran...ainment. Their AUTO-LOCK rotor exchange system wit...y for use within seconds. Instant rotor exchange...
Sterile, individually wrapped, 4mm Cuvettes
Biology Products: